• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钾通道开放剂需要ATP与磺脲类受体结合并通过该受体起作用。

Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.

作者信息

Schwanstecher M, Sieverding C, Dörschner H, Gross I, Aguilar-Bryan L, Schwanstecher C, Bryan J

机构信息

Institut für Pharmakologie und Toxikologie, Universität Braunschweig, Mendelssohnstrasse 1, 38106 Braunschweig, Germany.

出版信息

EMBO J. 1998 Oct 1;17(19):5529-35. doi: 10.1093/emboj/17.19.5529.

DOI:10.1093/emboj/17.19.5529
PMID:9755153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1170881/
Abstract

KATP channels are composed of a small inwardly rectifying K+ channel subunit, either KIR6.1 or KIR6.2, plus a sulfonylurea receptor, SUR1 or SUR2 (A or B), which belong to the ATP-binding cassette superfamily. SUR1/KIR6.2 reconstitute the neuronal/pancreatic beta-cell channel, whereas SUR2A/KIR6.2 and SUR2B/KIR6.1 (or KIR6.2) are proposed to reconstitute the cardiac and the vascular-smooth-muscle-type KATP channels, respectively. We report that potassium channel openers (KCOs) bind to and act through SURs and that binding to SUR1, SUR2A and SUR2B requires ATP. Non-hydrolysable ATP-analogues do not support binding, and Mg2+ or Mn2+ are required. Point mutations in the Walker A motifs or linker regions of both nucleotide-binding folds (NBFs) abolish or weaken [3H]P1075 binding to SUR2B, rendering reconstituted SUR2B/KIR6.2 channels insensitive towards KCOs. The C-terminus of SUR affects KCO affinity with SUR2B approximately SUR1 > SUR2A. KCOs belonging to different structural classes inhibited specific [3H]P1075 binding to SUR2B in a monophasic manner, with the exception of minoxidil sulfate, which induced a biphasic displacement. The affinities of KCO binding to SUR2B were 3.5-8-fold higher than their potencies for activation of SUR2B/KIR6.2 channels. The results establish that SURs are the KCO receptors of KATP channels and suggest that KCO binding requires a conformational change induced by ATP hydrolysis in both NBFs.

摘要

KATP通道由一个内向整流性小K⁺通道亚基(KIR6.1或KIR6.2)和一个磺脲类受体(SUR1或SUR2(A或B))组成,后者属于ATP结合盒超家族。SUR1/KIR6.2重构神经元/胰腺β细胞通道,而SUR2A/KIR6.2和SUR2B/KIR6.1(或KIR6.2)分别被认为重构心脏和血管平滑肌型KATP通道。我们报道钾通道开放剂(KCOs)通过SURs结合并发挥作用,且与SUR1、SUR2A和SUR2B的结合需要ATP。不可水解的ATP类似物不支持结合,且需要Mg²⁺或Mn²⁺。两个核苷酸结合结构域(NBFs)的沃克A基序或连接区的点突变消除或减弱[³H]P1075与SUR2B的结合,使重构的SUR2B/KIR6.2通道对KCOs不敏感。SUR的C末端对KCO与SUR2B的亲和力影响约为SUR1 > SUR2A > SUR2B。除硫酸米诺地尔诱导双相置换外,不同结构类别的KCOs以单相方式抑制[³H]P1075与SUR2B的特异性结合。KCO与SUR2B结合的亲和力比它们激活SUR2B/KIR6.2通道的效力高3.5 - 8倍。结果表明SURs是KATP通道的KCO受体,并提示KCO结合需要由两个NBFs中ATP水解诱导的构象变化。

相似文献

1
Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.钾通道开放剂需要ATP与磺脲类受体结合并通过该受体起作用。
EMBO J. 1998 Oct 1;17(19):5529-35. doi: 10.1093/emboj/17.19.5529.
2
Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure.磺脲类药物诱导的ATP敏感性钾通道关闭的化学计量学。
Mol Pharmacol. 1999 Jun;55(6):1060-6. doi: 10.1124/mol.55.6.1060.
3
Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.新型二氢吡啶钾通道开放剂A-312110与重组磺酰脲受体及KATP通道的相互作用:与氰基胍P1075的比较
Br J Pharmacol. 2004 Apr;141(7):1098-105. doi: 10.1038/sj.bjp.0705718. Epub 2004 Mar 15.
4
ATP-Sensitive K+ channel modulator binding to sulfonylurea receptors SUR2A and SUR2B: opposite effects of MgADP.ATP敏感性钾通道调节剂与磺脲类受体SUR2A和SUR2B的结合:MgADP的相反作用
Mol Pharmacol. 1999 May;55(5):832-40.
5
Differential response of K(ATP) channels containing SUR2A or SUR2B subunits to nucleotides and pinacidil.包含SUR2A或SUR2B亚基的K(ATP)通道对核苷酸和平那地尔的差异反应。
Mol Pharmacol. 2000 Dec;58(6):1318-25. doi: 10.1124/mol.58.6.1318.
6
Characterization of K(ATP)-channels in rat basilar and middle cerebral arteries: studies of vasomotor responses and mRNA expression.大鼠基底动脉和大脑中动脉中K(ATP)通道的特性:血管舒缩反应及mRNA表达的研究
Eur J Pharmacol. 2005 Oct 31;523(1-3):109-18. doi: 10.1016/j.ejphar.2005.08.028. Epub 2005 Oct 13.
7
The Kir6.2-F333I mutation differentially modulates KATP channels composed of SUR1 or SUR2 subunits.Kir6.2-F333I突变对由SUR1或SUR2亚基组成的KATP通道有不同的调节作用。
J Physiol. 2007 Jun 15;581(Pt 3):1259-69. doi: 10.1113/jphysiol.2007.130211. Epub 2007 Mar 29.
8
NMR and fluorescence studies of drug binding to the first nucleotide binding domain of SUR2A.NMR 和荧光研究药物与 SUR2A 的第一个核苷酸结合域的结合。
Biochemistry. 2012 Nov 13;51(45):9211-22. doi: 10.1021/bi301019e. Epub 2012 Nov 1.
9
C-terminal tails of sulfonylurea receptors control ADP-induced activation and diazoxide modulation of ATP-sensitive K(+) channels.磺酰脲受体的C末端尾巴控制ADP诱导的ATP敏感性钾通道的激活以及二氮嗪对其的调节。
Circ Res. 2000 Nov 10;87(10):873-80. doi: 10.1161/01.res.87.10.873.
10
Characterization of a mutant sulfonylurea receptor SUR2B with high affinity for sulfonylureas and openers: differences in the coupling to Kir6.x subtypes.对磺脲类药物和开放剂具有高亲和力的突变型磺脲类受体SUR2B的特性:与Kir6.x亚型偶联的差异。
Mol Pharmacol. 2001 Jul;60(1):190-9. doi: 10.1124/mol.60.1.190.

引用本文的文献

1
Meningeal K ATP channels contribute to behavioral responses in preclinical migraine models.脑膜KATP通道在临床前偏头痛模型中对行为反应有影响。
Pain. 2025 Feb 1;166(2):398-407. doi: 10.1097/j.pain.0000000000003385. Epub 2024 Oct 1.
2
ATP-gated potassium channels contribute to ketogenic diet-mediated analgesia in mice.ATP门控钾通道有助于生酮饮食介导的小鼠镇痛作用。
Neurobiol Pain. 2023 Jul 3;14:100138. doi: 10.1016/j.ynpai.2023.100138. eCollection 2023 Aug-Dec.
3
The inhibition mechanism of the SUR2A-containing K channel by a regulatory helix.含 SUR2A 的 K 通道受调节螺旋抑制的机制。
Nat Commun. 2023 Jun 17;14(1):3608. doi: 10.1038/s41467-023-39379-4.
4
Pharmacological Profiling of K Channel Modulators: An Outlook for New Treatment Opportunities for Migraine.钾通道调节剂的药理学剖析:偏头痛新治疗机遇展望
Pharmaceuticals (Basel). 2023 Feb 1;16(2):225. doi: 10.3390/ph16020225.
5
Synthesis and SAR of a novel Kir6.2/SUR1 channel opener scaffold identified by HTS.通过高通量筛选发现的新型 Kir6.2/SUR1 通道 opener 支架的合成及 SAR 研究。
Bioorg Med Chem Lett. 2023 May 1;87:129256. doi: 10.1016/j.bmcl.2023.129256. Epub 2023 Mar 24.
6
Omega-3 polyunsaturated fatty acid-induced vasodilation in mouse aorta and mesenteric arteries is not mediated by ATP-sensitive potassium channels.ω-3多不饱和脂肪酸诱导的小鼠主动脉和肠系膜动脉血管舒张并非由ATP敏感性钾通道介导。
Front Physiol. 2022 Dec 15;13:1033216. doi: 10.3389/fphys.2022.1033216. eCollection 2022.
7
Personalized Therapeutics for K-Dependent Pathologies.个体化治疗依赖 K 的病理。
Annu Rev Pharmacol Toxicol. 2023 Jan 20;63:541-563. doi: 10.1146/annurev-pharmtox-051921-123023. Epub 2022 Sep 28.
8
Structural identification of vasodilator binding sites on the SUR2 subunit.血管扩张剂结合部位在 SUR2 亚基上的结构鉴定。
Nat Commun. 2022 May 13;13(1):2675. doi: 10.1038/s41467-022-30428-y.
9
Mitochondrial outer membrane permeabilization at the single molecule level.线粒体在外膜水平的通透性:单分子视角
Cell Mol Life Sci. 2021 Apr;78(8):3777-3790. doi: 10.1007/s00018-021-03771-4. Epub 2021 Feb 12.
10
α-Synuclein Aggregates Increase the Conductance of Substantia Nigra Dopamine Neurons, an Effect Partly Reversed by the KATP Channel Inhibitor Glibenclamide.α-突触核蛋白聚集增加黑质多巴胺神经元的电导率,该效应部分可被 KATP 通道抑制剂格列本脲逆转。
eNeuro. 2021 Jan 14;8(1). doi: 10.1523/ENEURO.0330-20.2020. Print 2021 Jan-Feb.

本文引用的文献

1
Binding of K(ATP) channel modulators in rat cardiac membranes.大鼠心肌细胞膜中K(ATP)通道调节剂的结合
Br J Pharmacol. 1998 Apr;123(7):1395-402. doi: 10.1038/sj.bjp.0701756.
2
The effects of nucleotides and potassium channel openers on the SUR2A/Kir6.2 complex K+ channel expressed in a mammalian cell line, HEK293T cells.核苷酸和钾通道开放剂对在哺乳动物细胞系HEK293T细胞中表达的SUR2A/Kir6.2复合钾通道的影响。
Pflugers Arch. 1998 Apr;435(5):595-603. doi: 10.1007/s004240050559.
3
Toward understanding the assembly and structure of KATP channels.迈向对KATP通道组装和结构的理解。
Physiol Rev. 1998 Jan;78(1):227-45. doi: 10.1152/physrev.1998.78.1.227.
4
ATP hydrolysis cycles and mechanism in P-glycoprotein and CFTR.P-糖蛋白和囊性纤维化跨膜传导调节因子中的ATP水解循环及机制。
Semin Cancer Biol. 1997 Jun;8(3):143-50. doi: 10.1006/scbi.1997.0065.
5
Regulation of KATP channel activity by diazoxide and MgADP. Distinct functions of the two nucleotide binding folds of the sulfonylurea receptor.二氮嗪和MgADP对KATP通道活性的调节。磺脲类受体两个核苷酸结合结构域的不同功能。
J Gen Physiol. 1997 Dec;110(6):643-54. doi: 10.1085/jgp.110.6.643.
6
MgADP antagonism to Mg2+-independent ATP binding of the sulfonylurea receptor SUR1.MgADP对磺脲类受体SUR1的不依赖Mg2+的ATP结合的拮抗作用。
J Biol Chem. 1997 Sep 12;272(37):22983-6. doi: 10.1074/jbc.272.37.22983.
7
Nucleotide regulation and characteristics of potassium channel opener binding to skeletal muscle membranes.核苷酸对钾通道开放剂与骨骼肌膜结合的调节作用及特性
Mol Pharmacol. 1997 Sep;52(3):473-81. doi: 10.1124/mol.52.3.473.
8
The ABCs of ATP-sensitive potassium channels: more pieces of the puzzle.ATP敏感性钾通道的基础知识:谜团的更多碎片。
Curr Opin Cell Biol. 1997 Aug;9(4):553-9. doi: 10.1016/s0955-0674(97)80033-6.
9
Association and stoichiometry of K(ATP) channel subunits.K(ATP)通道亚基的关联与化学计量学
Neuron. 1997 May;18(5):827-38. doi: 10.1016/s0896-6273(00)80321-9.
10
Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor.在没有磺酰脲受体的情况下,Kir6.2的截短会产生ATP敏感性钾通道。
Nature. 1997 May 8;387(6629):179-83. doi: 10.1038/387179a0.